Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single Arm, Phase 1 Study to Assess the Safety of P2Et Extract Obtained From Caesalpinia Spinosa, in Voluntary Subjects in Colombia

NCT03663881 is registered in ClinicalTrials.gov with Hospital Universitario San Ignacio as lead sponsor.

NCT NCT03663881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single Arm, Phase 1 Study to Assess the Safety of P2Et Extract Obtained From Caesalpinia Spinosa, in Voluntary Subjects in Colombia
Lead sponsor
Hospital Universitario San Ignacio
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2019
Completion date
May 15, 2020
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues, toxicity